Eye Drops to Slow Nearsightedness in Children
Part of Eyes & vision clinical trials.
This study tests a new eye drop medicine (T10430) to see if it can slow down how fast children's nearsightedness gets worse. The trial will measure whether the drops are safe and effective for kids ages 6–11.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 6 and 11 years old
- Nearsightedness is between -1.00 and -6.00 diopters in each eye
- Eye pressure is below 21 mmHg in each eye
- Vision is at least 20/25 in each eye after best correction
- No significant astigmatism (curved cornea), eye disease, or allergy to the eye drops
- Parent or guardian can commit to all study visits and follow instructions
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an eye drop (QLM3004) to see if it can slow down the progression of nearsightedness (myopia) in children. It might be a good option if your child is between 6 and 12, has mild to moderate nearsightedness, and hasn't used other myopia treatments before.
This study tests whether special glasses or low-dose atropine eye drops can slow down worsening nearsightedness in children. It compares four groups: glasses alone, eye drops alone, both together, or a placebo (no active treatment).
This study compares two ways to slow down worsening nearsightedness in children: special electronic glasses versus low-dose atropine eye drops. It may help your child keep their eyesight from getting much worse over time.
This study tests whether a very low-dose atropine eye drop (0.01%) can safely slow down worsening nearsightedness in children. It is for kids ages 3 to 12 who are already nearsighted but haven't used other myopia control treatments before.
This trial tests whether brimonidine eye drops can slow down worsening nearsightedness (myopia) in children. It aims to find a non-invasive way to help prevent vision from getting more nearsighted.
This study tests whether low-dose atropine eye drops can prevent or slow down nearsightedness in children ages 6–11 who don't yet need glasses. The goal is to keep children's vision stable and reduce their need for corrective lenses as they grow.
Hear when a new Myopia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.